We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Bilateral pleural effusion and interstitial lung disease as unusual manifestations of kikuchi-fujimoto disease: case report and literature review
BMC Pulmonary Medicinevolume 10, Article number: 54 (2010)
Kikuchi-Fujimoto's disease (KFD), also called histiocytic necrotizing lymphadenitis, is a rare, idiopathic and self-limited condition usually characterized by cervical lymphadenopathy and fever, most often affecting young patients. Aetiology is unknown. Differential diagnosis includes mainly malignant lymphoma, tuberculous lymphadenitis and systemic lupus erythematosus (SLE), so early diagnosis is crucial. Pleuropulmonary involvement due to isolated KFD has been seldom reported.
a 32-year-old man, on treatment for iatrogenic hypothyroidism, was admitted due to high grade fever and painful cervical lymphadenopathies. KFD was diagnosed by lymph node biopsy. Some days after admission the patient got worse, he developed generalized lymphadenopathy, bilateral pleural effusion and interstitial lung disease. All of them resolved with prednisone and after two years of following up he remains asymptomatic and without evidence of any other associated disease.
Pleural effusion and interstitial lung disease are very uncommon manifestations of KFD. In our experience, treatment with oral prednisone was effective.
Kikuchi-Fujimoto's disease (KFD), or histiocytic necrotizing lymphadenitis, was first described in Japan in 1972 as a self-limiting disease mostly affecting the cervical lymph nodes of young individuals, mainly females . In 1982 the first cases of KFD were reported in North America and Europe  and the disease is now reported worldwide. Although the aetiology is unknown, it has been suggested to be an apoptotic process mediated mainly by CD8-positive T lymphocytes, and viral or autoimmune factors are believed to be involved [1, 3]. Occasionally it may be associated with autoimmune disease, mostly systemic lupus erythematosus (SLE) [3, 4]. Enlargement of cervical lymph nodes, fever and leukopenia are the most prominent symptoms, although several other clinical manifestations have been reported [1, 3]. The authors report the first case of isolated KFD with interstitial lung disease and bilateral pleural effusion, which also improved quickly with oral prednisone.
A 32-year-old Caucasian man, with a history of hyperthyroidism six months previous due to toxic multinodular goiter, treated with radioactive iodine, who developed iatrogenic hypothyroidism and on initiation of substitutive treatment, was admitted due to persistent fever (39-40°C), malaise and painful cervical lymphadenopathies that had been present for two weeks. Laboratory findings were as follows: haematocrit 34%, haemoglobin 12 g/dl, leukocyte count 3400/mm3 (neutrophils 88.2%, lymphocytes 8.7%, monocytes 2.8%), platelet count 246000/mm3, erythrocyte sedimentation rate 63 mm/h (normal range 0-20 mm/h), alanine transferase (ALT) 176 IU/L (0-40 IU/L), aspartate aminotransferase (AST) 89 IU/L (0-40 IU/L), alkaline phosphatase (AlkP) 176 IU/L (40-129 IU/L) and gamma-glutamyl transpeptidase (GGT) 657 IU/L (10-50 IU/L); serum lactic dehydrogenase (LDH) 1896 IU/L (240-480 IU/L), thyroid-stimulating hormone (TSH) 73 μIU/ml (0.27-4.2 μIU/ml) and thyroxine (T4) 0,25 ng/dl (NR:0.93-1.71). Blood cultures and serologic tests were found to be negative for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), herpes simplex virus (HSV), Rubella, Toxoplasma, parvovirus B19, Yersinia enterocolitica, Salmonella and Brucella. Serum antinuclear antibody (ANA) and rheumatoid factor were also negative. On admission, chest X-ray was clear in both lung fields and computed tomography of the neck, thorax and abdomen revealed only lymphadenopathy affecting bilateral cervical and one mediastinal lymph nodes (Figure 1). Cervical lymph node surgical biopsy was performed on the second day after admission. On macroscopic examination it appeared homogeneous, of medium consistency, dark grey colour and 2 × 1.2 × 1.1 cm in size. The patient's condition worsened over the following days, with high-grade daily fever, increasing size of cervical lymph nodes, the development of axillary lymphadenopathy and mild dyspnoea on exertion, with decreased breath sounds in both lung bases on physical examination. A second computed tomography of the thorax revealed generalized axillary, mediastinal and hilar lymphadenopathy, interstitial infiltrate in both lungs and bilateral pleural effusion (Figure 2). Thoracocentesis was performed with the following results in pleural fluid: pH 7.39 (6.8-7.6), glucose 102 mg/dl (60-100), proteins 3.2 g/dl (0-3), LDH 1694 IU/L (0-200), 50 leukocytes/ml (0-300); stains and cultures for bacteria and mycobacteria were negative and malignant cells were not found on cytologic examination. Cervical lymph node biopsy revealed necrotizing lymphadenitis with prominent areas of cortical and paracortical necrosis and distortion of the nodal architecture (Figure 3), abundant non-neutrophilic karyorrhexis and large numbers of various types of histiocytes at the margins of the necrotic areas, performing phagocytosis of cellular debris. Stimulated lymphocytes and immunoblasts were observed around these areas, along with reduced numbers of plasma cells and no neutrophils (Figure 4). Lymphoma cells were absent and stains and tissue cultures for bacteria, fungi and mycobacteria were negative. Prednisone therapy was started on the 7th day (after receiving negative viral results) at a dose of 1 mg/kg/day, with rapid improvement: the patient became afebrile on day 10, cervical and axillary swelling and tenderness began to decrease, dyspnoea disappeared and respiratory auscultation normalized. The daily dose of thyroxine was slowly increased by the endocrinologist. Prior to discharge, chest X-ray was normal. Tapering doses of prednisone were prescribed throughout the subsequent two months; all biochemical and haematological parameters normalized except for TSH, which reached normal values four months later. After two years of follow-up appointments the patient remains asymptomatic, physical examination and chest X-ray are absolutely normal and serum antinuclear antibodies remain negative.
KFD is a benign disease that usually resolves spontaneously within one to four months, affects all ethnic groups and is more common in young women (4:1 female:male ratio), manifests as localized lymphadenopathy, usually in the cervical region, and is commonly associated with fever and leukopenia [1, 5]. The aetiology of KFD remains obscure: a viral pathogenesis is thought to be the most likely candidate due to its self-limiting clinical course and the lack of neutrophilic response [4, 6]. It has been reported in association with Epstein-Barr virus, human herpesvirus, human herpesvirus 8, HIV, HTLV1, dengue virus, parvovirus B19, Yersinia enterocolítica, Bartonella, Brucella, Entamoeba histolytica and Toxoplasma [7, 8]. On the other hand, an autoimmune origin has also been suggested due to electron microscopic studies that have identified tubular reticular structures in the cytoplasm of stimulated lymphocytes and histiocytes in patients with KFD, which have also been noted within lymphocytes and endothelial cells of patients with systemic lupus erythematosus and other autoimmune disorders, so it is possible that KFD may represent an exuberant T-cell-mediated, self-limited immune response to a variety of non-specific stimuli in genetically susceptible individuals .
The differential diagnosis of lymph node enlargement in patients with the clinical signs of KFD includes mainly tuberculous and other infectious types of lymphadenitis, and malignant lymphoma . The diagnosis is confirmed by lymph node biopsy, when histopathology reveals necrotizing lymphadenitis restricted to the cortical and paracortical areas, with partial or complete loss of follicular architecture, marked karyorrhexis and absence of neutrophils, granulomatous reaction or lymphoma cells . Most KFD cases improve within a six-month period , and a wide range of recurrence rates have been reported, from 4% to 27% [10–12].
Kikuchi-Fujimoto disease has occasionally been described in association with simultaneous SLE [4, 5], Sjögren syndrome , antiphospholipid syndrome [4, 14], relapsing polychondritis  or even autoimmune hepatitis . On the other hand, unusual manifestations of isolated KFD include axillary and mesenteric lymphadenopathy, splenomegaly, parotid gland enlargement, skin rashes, arthralgias, myalgias, aseptic meningitis, bone marrow haemophagocytosis and liver dysfunction . Patients with arthritis [17, 18] or bilateral panuveitis  have been reported on occasion. KFD has seldom been reported in association with pulmonary involvement  and most such cases have been in patients who developed SLE . Wilkinson et al. described a 41-yr-old lady diagnosed with KFD who subsequently developed polymyositis with pulmonary involvement . Meanwhile, Kucukardali et al. reported one case of fatal pulmonary haemorrhage due to KFD upon post-mortem examination and three cases who developed KFD after transplantation and died of respiratory failure . Finally, one case of KFD associated with cryptogenic organizing pneumonia has been reported recently . In the present case, the patient developed isolated KFD with pleuropulmonary involvement due to interstitial lung infiltrate and pleural effusion, both bilateral and with rapid improvement and resolution with oral prednisone. The simultaneous hypothyroidism of the patient should not be ignored, nor its possible clinical co-expression. However, its presence several months before the development of KFD and even after the clinical and analytical resolution of the latter, combined with the absence of any other clinical symptoms related to thyroxine defficiency and the rapid development and improvement of the pleuropulmonary manifestations with prednisone, suggest an inflammatory rather than an endocrine aetiology.
In conclusion, pleuropulmonary involvement in patients with KFD has seldom been reported. We describe a patient with isolated KFD in whom bilateral pleural effusion and an interstitial lung pattern developed. Clinical and radiological responses to prednisone were excellent.
Disclosures: Conflicts of interests
The authors declare that they have no competing interests.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Koybasi S, Saydam L, Gungen Y: Histiocytic Necrotizing Lymphadenitis of the neck. Am J Otolaryngol. 2003, 24: 344-347. 10.1016/S0196-0709(03)00061-9.
Pileri S, Kikuchi M, Helbron D, Lennert K: Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol. 1982, 395: 257-271. 10.1007/BF00429352.
Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M: Kikuchi-Fujimoto disease: analysis of 244 cases. Clin Rheumatol. 2007, 26: 50-54. 10.1007/s10067-006-0230-5.
Chen HC, Lai JH, Huang GS, Gao HW, Chen CH, Kuo SY, Chang DM: Systemic lupus erythematosus with simultaneous onset of Kikuchi-Fujimoto's disease complicated with antiphospholipid antibody syndrome: a case report and review of the literature. Rheumatol Int. 2005, 25: 303-306. 10.1007/s00296-004-0507-4.
Santana A, Lessa B, Galrao L, Lima I, Mittermayer S: Kikuchi-Fujimoto's disease associated with systemic lupus erythematosus: case report and review of the literature. Clin Rheumatol. 2005, 24: 60-63. 10.1007/s10067-004-0923-6.
Hudnall SD, Chen T, Amr S, Young KH, Henry K: Detection of Human Herpesvirus DNA in Kikuchi-Fujimoto Disease and Reactive Lymphoid Hyperplasia. Int J Clin Exp Pathol. 2008, 1: 362-368.
Atwater AR, Longley J, Aughenbaugh WD: Kikuchi's disease: case report and systematic review of cutaneous and histopathologic presentations. J Am Acad Dermatol. 2008, 59: 130-136. 10.1016/j.jaad.2008.03.012.
Aydogan T, Kanbay M, Uraldi C, Kaya A, Uz B, Isik A, Akcay A, Erekul S: Kikuchi-Fujimoto disease secondary to Entamoeba histolytica: case report. J Infect. 2006, 53: 171-173. 10.1016/j.jinf.2005.12.007.
Bosch X, Guilabert A, Miquel R, Campo E: Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol. 2004, 122: 141-152. 10.1309/YF081L4TKYWVYVPQ.
Phupong V, Poomtavorn Y: Kikuchi disease during pregnancy. Arch Gynecol Obstet. 2006, 274: 393-396. 10.1007/s00404-006-0197-0.
Song JY, Lee J, Park DW, Sohn JW, Suh SI, Kim IS, Kim WJ, Kim MJ, Cheong HJ: Clinical outcome and predictive factors of recurrence among patients with Kikuchi's disease. Int J Infect Dis. 2009, 13: 322-326. 10.1016/j.ijid.2008.06.022.
Han HJ, Lim GY, Yeo DM, Chung NG: Kikuchi's disease in children: clinical manifestations and imaging features. J Korean Med Sci. 2009, 24: 1105-1109. 10.3346/jkms.2009.24.6.1105.
Soy M, Peynirci H, Bilgi S, Adali MK, Güresci S: Kikuchi-Fujimoto disease coexisted with Sjögren syndrome. Clin Rheumatol. 2007, 26: 607-608. 10.1007/s10067-005-0184-z.
Pappaioannou G, Speletas M, Kaloutsi V, Pavlitou-Tsiontsi A: Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) associated with antiphospholipid syndrome: case report and literature review. Ann Hematol. 2002, 81: 732-735. 10.1007/s00277-002-0562-4.
Mahajan T, Merriman RC, Stone MJ: Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): report of a case with other autoimmune manifestations. Proc (Bayl Univ Med Cent). 2007, 20: 149-151.
Shusang V, Marelli L, Beynon H, Davies N, Patch D, Dhillon AP, Burroughs AK: Autoimmune hepatitis associated with Kikuchi-Fujimoto disease. Eur J Gastroenterol Hepatol. 2008, 20: 79-82. 10.1097/MEG.0b013e32825a6a9e.
Douglas M, Bradbury R, Kannangara S, Mitchell D: Arthritis as an unusual manifestation of Kikuchi_Fujimoto disease. Rheumatology. 2003, 42: 1010-1012. 10.1093/rheumatology/keg247.
Graham LE: Kikuchi-Fujimoto disease and peripheral arthritis: a first!. Ann Rheum Dis. 2002, 61: 475-10.1136/ard.61.5.475.
Taguri AH, McIlwaine GG: Bilateral panuveitis: a possible association with Kikuchi-Fujimoto disease. Am J Ophthlmol. 2001, 132: 419-421. 10.1016/S0002-9394(01)00934-5.
Sharma OP: Unusual systemic disorders associated with interstitial lung disease. Curr Opin Pulm Med. 2001, 7: 291-294. 10.1097/00063198-200109000-00007.
Wilkinson CE, Nichol F: Kikuchi-Fujimoto disease associated with polymiositis. Rheumatology. 2000, 39: 1302-1304. 10.1093/rheumatology/39.11.1302.
Hua F, Zhu L: Kikuchi-Fujimoto disease associated with cryptogenic organizing pneumonia: case report and literature review. BMC Infect Dis. 2010, 10: 64-
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/10/54/prepub
The authors are grateful to Dr. J. Mar for his helpful advice during the preparation of this manuscript.
AGZ has contributed providing the clinical data, he has performed the literature review and he has written the main manuscript. He was involved in revising the manuscript critically for important intellectual content, and gave final approval of the version to be published. JTG was involved in revising the manuscript critically for important intellectual content, making substantial contributions and gave final approval of the version to be published. PBG was involved in revising the manuscript critically, and gave final approval of the version to be published. MFM was involved in revising the manuscript critically, and gave final approval of the version to be published. LZD provided the histopathological figures. She was involved in revising the manuscript critically, and gave final approval of the version to be published. MUM provided the Computed Tomography images and was involved in revising the manuscript critically, and gave final approval of the version to be published.